Actions of hepatocyte growth factor as a local modulator in the kidney: Potential role in pathogenesis of renal disease

Y. Yo(The University of Osaka), Toshio Ogihara(Osaka University), Naruya Tomita(M4 Engineering (United States)), Iwao Kida(The University of Osaka), Shin‐ichiro Kato(The University of Osaka), Shinichiro Hayashi(The University of Osaka), Kei Yamamoto(Japan Agency for Medical Research and Development), Toshikazu Nakamura(The University of Osaka), Atsushi Moriguchi(The University of Osaka), Kunio Matsumoto(Kanazawa University), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Ryuichi Morishita(The University of Osaka)
Kidney International
January 1, 1998
10.1046/j.1523-1755.1998.00726.x
Cited by 66

Related Papers

Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588